Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

propranolol hydrochloride

(proh-PRAN-uh-lol HY-droh-KLOR-ide)
A drug used under the brand name Hemangeol to treat infants 5 weeks to 5 months of age with infantile hemangioma (a benign blood vessel tumor) and under other brand names to treat high blood pressure, including before surgery in patients with pheochromocytoma, and many other conditions. It is also being studied in the treatment of other conditions and some types of cancer. Propranolol hydrochloride blocks certain receptors on nerve cells and causes blood vessels to relax and widen. This improves blood flow and lowers blood pressure and heart rate. Propranolol hydrochloride may also help shrink certain types of vascular tumors. It is a type of beta blocker.
More Information
Search NCI's Dictionary of Cancer Terms